jueves, 25 de abril de 2024

Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00095-1/fulltext?dgcid=hubspot_update_feature_updatealerts_ebiom&utm_campaign=update-ebiom&utm_medium=email&_hsenc=p2ANqtz--C9uFf17bDld_KsFhktdAzj4EqHRQJChOLm02QpL2G-MCN7SMYO99OgxoKWS07PMtrEXK0hhM4j-FukuK-9UEEda7z2Q&_hsmi=304176437&utm_content=304086102&utm_source=hs_email

No hay comentarios:

Publicar un comentario